Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor‐infiltrating immune cell analysis

BACKGROUND: Prognostic indicators in lung adenocarcinoma (LUAD) have been seeking under database analysis, and remarkable advance is on the way. METHODS: This study calculated the scores of stromal and immune components of the tumor microenvironment (TME) in 551 LUAD samples using the ESTIMATE algor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Yi, Wang, Xin, Liu, Ting, Fan, Tianyu, Zhang, Zugui, Wang, Bin, Zhang, Bei, Tian, Zibin, Mao, Tao, Gong, Zheng, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinfomatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209599/
https://www.ncbi.nlm.nih.gov/pubmed/33949150
http://dx.doi.org/10.1002/cam4.3931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209599/
https://www.ncbi.nlm.nih.gov/pubmed/33949150
http://dx.doi.org/10.1002/cam4.3931

Ejemplares similares